logo
Bridgewater Bank's Joe Chybowski Named a 2025 Notable Banking Leader by Twin Cities Business

Bridgewater Bank's Joe Chybowski Named a 2025 Notable Banking Leader by Twin Cities Business

Business Wire16-06-2025
BUSINESS WIRE)--Bridgewater Bank, a leading Twin Cities bank focused on meeting the unique needs of successful individuals and entrepreneurs, is pleased to announce that President and Chief Financial Officer Joe Chybowski has been recognized by Twin Cities Business as a 2025 Notable Banking Leader.
Part of Twin Cities Business 's ongoing Notable series, this annual feature highlights top-tier banking executives in Minnesota who are shaping the future of the financial industry. Honorees are selected based on their professional achievements, community involvement, and ability to drive meaningful change in their institutions and the markets they serve.
Joe's selection is a testament to his strategic leadership and deep impact at Bridgewater. Since joining the bank in 2013 as Controller, he has helped drive its transformation from a small de novo bank to one of the largest publicly traded banks in Minnesota, with assets growing from $460 million to $5.1 billion, largely through organic growth. As a young leader, Joe led Bridgewater's IPO, raising over $58 million and making it the first Minnesota state bank to go public in more than 25 years.
Now, as President and CFO, Joe drives the bank's strategic direction, advancing key scalability initiatives and leading strategic goal setting, enterprise risk management, capital deployment, and M&A evaluation. In 2024, he led Bridgewater's acquisition of First Minnetonka City Bank, a strategic expansion marking the bank's first M&A transaction since 2016.
'Joe's leadership has been instrumental in Bridgewater's success,' said Jerry Baack, Founder and Chief Executive Officer at Bridgewater Bank. 'He's known for his humble, people-first approach, unwavering dedication, and extraordinary ability to turn strategy into action. We're proud to see him recognized for the integral impact he makes across our organization every day.'
Beyond the boardroom, Joe is a dedicated mentor and active community member. From his tenure on the board of People Serving People to his robust history of volunteerism, Joe's people-first leadership and belief in giving back continue to make a meaningful impact, both at Bridgewater and throughout the broader community.
About Bridgewater Bank
Bridgewater Bancshares, Inc. (Nasdaq: BWB) is a St. Louis Park, Minnesota-based financial holding company founded in 2005. Its banking subsidiary, Bridgewater Bank, is a premier, full-service bank dedicated to providing responsive support and simple solutions to businesses, entrepreneurs, and successful individuals across the Twin Cities. Bridgewater offers a comprehensive suite of products and services spanning deposits, lending, and treasury management solutions. Bridgewater has also received numerous awards for its banking services and esteemed corporate culture. With total assets of $5.1 billion and nine strategically located branches as of March 31, 2025, Bridgewater is one of the largest locally-led banks in Minnesota and is committed to being the finest entrepreneurial bank. For more information, please visit www.bridgewaterbankmn.com.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Amazon (AMZN) Gets Price Target Hike After Strong Quarterly Performance
Amazon (AMZN) Gets Price Target Hike After Strong Quarterly Performance

Yahoo

time8 minutes ago

  • Yahoo

Amazon (AMZN) Gets Price Target Hike After Strong Quarterly Performance

Inc. (NASDAQ:) is one of the . On August 11, Freedom Broker analyst Egor Tolmachev raised the price target on the stock to $255.00 (from $240.00) while maintaining a Hold rating. The investment bank noted how Amazon has delivered strong financial results for the second quarter, surpassing both market expectations and its own guidance across all segments. Retail efficiency gains were particularly noted. The firm did note that AWS performance was mixed and Q3 profit forecast was cautious. Nevertheless, it revised its financial forecast based on its confidence in the company's ability to mitigate geopolitical risk and monetize continued logistics improvements. 'Q3 guidance came in well above revenue expectations but below profit forecasts, marking a second area of perceived weakness in the release. We view this as prudent management positioning in light of heightened geopolitical uncertainty. We have revised our financial forecasts upward, reflecting confidence in Amazon's ability to mitigate geopolitical risk and monetize continued logistics improvements. Despite the negative share price reaction, we see upside potential and reiterate our Buy rating, raising our target price from $240 to $255.' Inc. (NASDAQ:AMZN) is an American technology company offering e-commerce, cloud computing, and other services, including digital streaming and artificial intelligence solutions. While we acknowledge the potential of AMZN as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and Disclosure: None.

Judge orders liquidation of Infowars to pay Sandy Hook families
Judge orders liquidation of Infowars to pay Sandy Hook families

Boston Globe

time9 minutes ago

  • Boston Globe

Judge orders liquidation of Infowars to pay Sandy Hook families

Get Starting Point A guide through the most important stories of the morning, delivered Monday through Friday. Enter Email Sign Up AVIATION Advertisement Startup Merlin Labs valued at $800 million in deal to go public Merlin Labs wants to test its autonomous aviation software at Hanscom. Photo courtesy of Merlin Labs Autonomous aviation startup Merlin Labs will soon be soaring into the public markets now that it has signed a deal to merge with a blank-check company early next year. The terms of the deal, with a special purpose acquisition company managed by New York-based Inflection Point, values Boston-based Merlin at $800 million, prior to the results of a follow-on private purchase of shares. Merlin chief executive Matt George says the money raised by going public will help Merlin add more employees to its 170-person workforce and also provide capital for future acquisitions. Merlin is working on tech that will allow commercial and military planes to be flown with only one pilot, and eventually without one at all. George said the firm is close to signing a lease to take over much of a former Navy hangar in Bedford at Hanscom Field, once used to house a corporate jet fleet for defense contractor Raytheon (now RTX). Merlin could eventually employ as many as 200 people there. Last year, the company landed a $105 million contract with the Department of Defense to integrate Merlin Pilot software into the C-130J airlifter manufactured by Lockheed Martin. Inflection Point chief executive Mike Blitzer will join the Merlin board as a result of the upcoming deal; Inflection Point's recent successes include two other companies launched through similar SPAC deals, USA Rare Earth (current market cap of $1.7 billion) and Intuitive Machines (worth $1.6 billion today). — JON CHESTO Advertisement HEALTH CARE Costco will not sell abortion pills after pressure from conservatives A Costco Wholesale store in Everett. Jonathan Wiggs/Globe Staff/Boston Globe Costco will not dispense a key abortion pill at its pharmacies, a long-awaited win for conservatives trying to limit access to medication abortion. For more than a year, Costco deliberated over whether to become certified to dispense mifepristone, the drug used first in the typical two-step regimen for a medication abortion. The procedure, often easier and cheaper than the surgical alternative, is the option women in America most frequently choose to end pregnancies. Costco received pressure from groups on both sides of the issue, many of them investors in the nationwide grocery giant. The company's decision not to sell the pill, first reported by Bloomberg, is a victory for antiabortion advocates — but a narrow one. Despite lawsuits and letters pleading to lawmakers, their campaign to thwart access to abortion pills has otherwise been slow-moving. Patients can still access medication abortion in all 50 states, even those where the procedure is illegal, because of laws allowing the pills to be remotely prescribed and mailed. In a statement Thursday, Costco said the decision was 'based on the lack of demand from our members and other patients.' The company did not answer further questions from The Washington Post about the influence of outside groups. — WASHINGTON POST Advertisement SPORTS LA Olympics to sell naming rights to some venues in game-changing deal for 2028 Organizers of the Los Angeles Olympics will sell naming rights for a handful of its venues in deals expected to bring multiple millions of dollars to the 2028 Games while breaking down the International Olympic Committee's long-sacrosanct policy of keeping brand names off its arenas and stadiums. The organizing committee announced the landmark deal Thursday, saying contracts were already in place with two of its founding partners — Honda, which already has naming rights for the arena in Anaheim that will host volleyball, and Comcast, which will have its name on the temporary venue hosting squash. LA28 chairman and CEO Casey Wasserman said revenue from the deals goes above what's in LA's current $6.9 billion budget. He portrayed the deal as the sort of paradigm-shifting arrangement that Los Angeles needs more than other host cities because, as is typical for American-hosted Olympics, the core cost of these games aren't backed by government funding. — ASSOCIATED PRESS HOUSING Average rate on a 30-year mortgage drops to lowest level since October A "for sale" sign displayed in front of a single-family home on July 17, 2025, in Derry, N.H. Charles Krupa/Associated Press The average rate on a 30-year US mortgage fell this week to its lowest level in nearly 10 months, giving prospective homebuyers a sorely needed boost in purchasing power that could help inject life into a stagnant housing market. The long-term rate fell to 6.58 percent from 6.63 percent last week, mortgage buyer Freddie Mac said Thursday. A year ago, the rate averaged 6.49 percent. Borrowing costs on 15-year fixed-rate mortgages, popular with homeowners refinancing their home loans, also fell. The average rate dropped to 5.71 percent from 5.75 percent last week. A year ago, it was 5.66 percent, Freddie Mac said. Elevated mortgage rates have helped keep the US housing market in a sales slump since early 2022, when rates started to climb from the rock-bottom lows they reached during the pandemic. Home sales sank last year to their lowest level in nearly 30 years. This is the fourth week in a row that rates have come down. The latest average rate on a 30-year mortgage is now at its lowest level since Oct. 24, when it averaged 6.54 percent. — ASSOCIATED PRESS Advertisement PHILANTHROPY Nike cofounder Phil Knight and wife give record $2 billion to Oregon cancer center, university says In this Sept. 26, 2015, file photo, Nike cofounder Phil Knight watched from the sidelines during the second half of an NCAA college football game between Oregon and Utah in Eugene, Ore. Ryan Kang/Associated Press Nike cofounder Phil Knight and his wife Penny Knight have pledged to donate $2 billion to Oregon Health & Science University's Knight Cancer Institute, the university announced Thursday, describing it as a record-breaking gift. 'This gift is an unprecedented investment in the millions of lives burdened with cancer, especially patients and families here in Oregon,' OHSU President Shereef Elnahal said in a statement. The donation will help ensure patients have access to various resources, including psychological, genetic, and financial counseling, symptom management, nutritional support and survivorship care, the university statement said. The university described it as the 'largest single donation ever made to a US university, college or academic health center.' It surpasses the $1.8 billion given by Michael Bloomberg to Johns Hopkins in 2018, described by that university at the time as the largest single contribution to a US university. Bloomberg also donated an additional $1 billion to Johns Hopkins last year, covering tuition, living expenses, and fees for students from families under certain income levels. — ASSOCIATED PRESS Advertisement CONSUMER SAFETY Werner recalls more than 100,000 ladders due to potential fall and injury hazard Werner on Thursday said it is recalling more than 100,000 faulty ladders due to a locking mechanism that can fail, potentially causing users to fall and injure themselves. In cooperation with federal consumer product regulators, Werner is recalling 122,250 Multi-Max Pro ladders that come in 20-foot and 24-foot sizes. The ladders were sold exclusively at Home Depot between November of 2021 and February of 2024 with prices between $200 and $281. The Illinois-based company said owners of the ladders being recalled should stop using them immediately and register at to begin the process for a full refund. Once owners have properly disposed of their ladders per Werner's instructions, the company said it will issue a check for a full refund. The ladders are silver with a blue top and a blue label on the side rail with an oval containing the word 'Werner' and 'MULTI MAX PRO.' The size and model numbers are ALMP-20IAA or ALMP-24IAA and have a long black rope in the back. Werner said it has received 18 reports of falls, including 14 reports of injuries resulting in bruising, lacerations, head injuries, and fractures to the wrist, leg, and ribs. — ASSOCIATED PRESS

Vyome closes Merger Transaction, Will Trade on Nasdaq as HIND Tomorrow
Vyome closes Merger Transaction, Will Trade on Nasdaq as HIND Tomorrow

Business Wire

time39 minutes ago

  • Business Wire

Vyome closes Merger Transaction, Will Trade on Nasdaq as HIND Tomorrow

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vyome Therapeutics, Inc. ('Vyome'), a clinical-stage healthcare company targeting immuno-inflammatory and rare diseases in the US and global markets with large market potential, today announced that it has closed the previously disclosed transaction with ReShape Lifesciences Inc. (Nasdaq: RSLS). The post-merger company will trade at the open of trading on Friday, August 15, 2025 under the name Vyome Holdings, Inc. and the trading symbol 'HIND.' About Vyome Vyome is building a healthcare platform spanning the US-India innovation corridor. Based in Cambridge, MA, Vyome's immediate focus is leveraging its clinical-stage assets to transform the lives of patients with immuno-inflammatory conditions. By applying groundbreaking science and its unique positioning across the US-India innovation corridor, Vyome seeks to deliver lasting value to shareholders in a hyper cost-efficient manner while upholding global standards of quality and safety. To learn more, please visit Visit us on social media: Facebook X LinkedIn Forward-Looking Statements Certain statements made in this press release are 'forward-looking statements' within the meaning of the 'safe harbor' provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as 'target,' 'believe,' 'expect,' 'will,' 'shall,' 'may,' 'anticipate,' 'estimate,' 'would,' 'positioned,' 'future,' 'forecast,' 'intend,' 'plan,' 'project,' 'outlook', and other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. Examples of forward-looking statements include, among others, statements made in this report regarding the merger, including the benefits of the merger, revenue opportunities, anticipated future financial and operating performance, and results, including estimates for growth. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on management's current beliefs, expectations, and assumptions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of Vyome's control. Actual results and outcomes may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause actual results and outcomes to differ materially from those indicated in the forward-looking statements include, among others, the following: (a) the occurrence of any event, change, or other circumstances relating to the combined company; (b) failure to obtain the necessary consents and approvals; (c) the risk that the merger disrupts current plans and operations as a result of the announcement and consummation of the merger; (e) costs related to the merger; and (f) changes in applicable laws or regulations. Vyome cautions that the foregoing list of factors is not exhaustive. Vyome cautions readers not to place undue reliance upon any forward-looking statements, which speak only as of the date made. Vyome does not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations or any change in events, conditions, or circumstances on which any such statement is based, whether as a result of new information, future events, or otherwise, except as may be required by applicable law.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store